A Novel Analgesic Peptide Drug has Passed its Pre-clinical Research Phase The pre-clinical research of a new analgesic peptide drug, which is the largest single-funded project in Hainan Province and lasted for five years has finally been completed successfully by the cooperation of the leading organization Hainan University, the Institute of Toxicology and Drugs of the Military Academy of Sciences, and the company GL Biochem (Shanghai) Ltd, who overcame various difficulties and challenges during the five years.
Thanks for reading. If you enjoyed this newsletter, please share with colleagues, friends and anybody else, get them to sign up and join the conversation. You can contact us at firstname.lastname@example.org.
Up-to-date international news and features on the Healthcare industry
You are receiving this email because you are either a valued subscriber to Verdict Pharmaceutical Technology or have signed up via a partner website. Your email address has not been, and will not be, given to third parties.